Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_assertion type Assertion NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_head.
- NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_provenance.
- NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_assertion evidence source_evidence_literature NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_provenance.
- NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_assertion SIO_000772 25339352 NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_provenance.
- NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_assertion wasDerivedFrom befree-20150227 NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_provenance.
- NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_assertion wasGeneratedBy ECO_0000203 NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_provenance.